Examination Report |
1 | Additional Representation Sheet | 03 Aug 2010 |
1 | TM-1 | 03 Aug 2010 |
10 | Refusal Notice | 29 Jun 2017 |
11 | Return post | 19 Jul 2017 |
2 | Additional Representation Sheet | 03 Aug 2010 |
2 | TM-1 | 03 Aug 2010 |
3 | Power of Attorney | 03 Aug 2010 |
4 | Examination Report | 22 Sep 2011 |
5 | Reply to Exam Report (MIS-R) | 30 Apr 2013 |
6 | Hearing Notice | 05 Oct 2016 |
7 | Return post | 25 Apr 2017 |
8 | Hearing Notice | 15 May 2017 |
9 | Note Sheet | 15 May 2017 |
1 | Hearing Notice (Adjourned) | 4692503 | 11 Apr 2017 | |
2 | Tribunal Refused Notice for : 2002795 | 4855320 | 20 Jun 2017 |
As per IP India data the trademark was applied on 03 August 2010.
REGENIX DRUGS applied for Renosave.
Listed class of trademark Renosave is 5.
Renosave is on the Refused stage of the trademark process.
Serial Number provided to trademark application is 2002795
Trademark application was filed by the following attorney agent:
Nair & Nair Associates
The trademark is categorized as WORD.